GlassScriptPhysician profile
Paul K Kim
NPI 1588699284
$13,707.68
in general payments reported to CMS, 2019-2025
58 companies · $2,407 in 2025
The $2,407 reported for 2025 was more than what 95% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,012 · 2020: $557 · 2021: $1,076 · 2022: $2,146 · 2023: $2,713 · 2024: $2,796 · 2025: $2,407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,631 · Travel and Lodging: $266 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,630.62 |
| Travel and Lodging | $265.65 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,420.98 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,098.71 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $989.56 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Pfizer INC. | $909.42 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $881.42 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $785.31 | 2019-2025 | Jardiance |
| Kci USA, INC. | $751.66 | 2021-2023 | Tegaderm, Prevena, 3m Cavilon |
| Bayer Healthcare Pharmaceuticals INC. | $702.34 | 2021-2025 | |
| Abbvie INC. | $610.88 | 2021-2025 | |
| Amgen INC. | $593.79 | 2020-2025 | Repatha, Evenity, Otezla |
| Janssen Pharmaceuticals, INC | $588.86 | 2019-2023 | Xarelto |
| Abbott Laboratories | $547.00 | 2021-2025 | Freestyle Libre 3, Ensite Precision |
| Stryker Corporation | $327.24 | 2019 | |
| Astellas Pharma US INC | $308.61 | 2019-2025 | Veozah, Myrbetriq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $229.05 | 2019-2025 | Xifaxan, Trulance |
Show all 58 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $220.18 | 2019-2025 | Eliquis |
| Eisai INC. | $217.73 | 2020-2025 | |
| Amarin Pharma, INC. | $208.54 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $193.23 | 2019-2023 | |
| Exact Sciences Corporation | $138.71 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Merck Sharp & Dohme LLC | $132.48 | 2019-2023 | Dificid |
| Shield Therapeutics INC | $126.00 | 2023-2024 | |
| Dexcom, INC. | $124.23 | 2023-2025 | Dexcom G6 Transmitter |
| Xeris Pharmaceuticals, INC. | $104.39 | 2022-2024 | Gvoke Hypopen |
| Smith+Nephew, INC. | $97.43 | 2024 | Renasys Touch |
| Teva Pharmaceuticals USA, INC. | $96.55 | 2022-2023 | Austedo Xr, Austedo |
| Sanofi-Aventis U.S. LLC | $96.23 | 2019-2025 | |
| Allergan, INC. | $93.90 | 2019-2020 | |
| Avvisto Therapeutics, LLC | $92.38 | 2024-2025 | Cycloset |
| Biohaven Pharmaceuticals, INC. | $84.42 | 2021 | |
| Rti Surgical, INC | $83.33 | 2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $80.39 | 2022 | |
| Sumitomo Pharma America, INC. | $70.62 | 2024-2025 | Gemtesa |
| Aimmune Therapeutics, INC. | $60.31 | 2024-2025 | Zenpep |
| Biogen, INC. | $49.97 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $45.71 | 2023 | Qelbree, Xyosted |
| Azurity Pharmaceuticals, INC. | $43.65 | 2024 | Horizant |
| Idorsia Pharmaceuticals US INC | $41.57 | 2022-2023 | Quviviq |
| Avanir Pharmaceuticals, INC. | $36.52 | 2019 | |
| Melinta Therapeutics, LLC | $35.12 | 2019 | |
| Corium, LLC | $34.43 | 2022 | |
| Arbor Pharmaceuticals, INC. | $33.06 | 2021 | |
| Inari Medical, INC. | $29.24 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Genentech USA, INC. | $29.22 | 2020-2021 | |
| Sunovion Pharmaceuticals INC. | $28.51 | 2020-2022 | |
| Radius Health, INC. | $24.61 | 2019 | |
| Insmed, INC. | $23.07 | 2025 | Brinsupri, Arikayce |
| Ironwood Pharmaceuticals, INC | $22.90 | 2020 | |
| Inspire Medical Systems, INC. | $20.23 | 2024 | Inspire |
| Seqirus USA INC | $20.15 | 2025 | Fluad, Flucelvax |
| Halozyme INC | $20.09 | 2023 | |
| Dynavax Technologies Corporation | $19.09 | 2025 | Heplisav-B |
| Cashflow Solutions, LLC | $18.39 | 2024 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Alvogen INC | $16.79 | 2025 | Teriparatide |
| Nestle Healthcare Nutrition INC. | $13.51 | 2022 | |
| Alnylam Pharmaceuticals INC. | $13.08 | 2021 | |
| Esperion Therapeutics, INC. | $11.74 | 2020 | |
| Gilead Sciences, INC. | $11.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.